The Role of Pharmacies in the HIV Prevention And Care Continuums: A Systematic Review

Overview

Journal AIDS Behav

Specialty Infectious Diseases

Date 2021 Jan 2

PMID 33386509

Citations 21

Authors

Natalie D Crawford

Sky Myers

Henry Young

Donald Klepser

Elyse Tung

Affiliations

Soon will be listed here.

Abstract

The role of pharmacists in the treatment of HIV has expanded beyond medication dispensing to include a host of cost-effective, evidence-based strategies across the HIV prevention and care continuums. However, wide-scale adoption of pharmacy-based HIV prevention and treatment interventions has been slow. We conducted a systematic review to evaluate the evidence on the role of pharmacists across the HIV prevention and care continuums. Thirty-two studies were identified, most of which provided evidence of feasibility of HIV testing and efficacy of non-prescription syringe sale services in pharmacies. However, only two studies implemented an experimental design to rigorously test pharmacy-based strategies. Notably, no pharmacy-based strategies have specifically targeted the highest HIV risk populations such as black and Latinx men who have sex with men, women, or trans populations. Efficacy trials and effectiveness studies should rigorously test existing pharmacy-based strategies to build greater support for wide-scale adoption and implementation. Moreover, in order to integrate pharmacies into the strategy to end the HIV epidemic, studies are needed to ensure that pharmacy-based HIV prevention and treatment services can reach the highest risk populations.

Citing Articles

Expanding HIV Self-Test Kits via Community Pharmacies in Rwanda Has Improved Availability, but Affordability Remains an Issue.

Nsengimana A, Biracyaza E, Manirakiza A, Nsekonziza Y, Niyonsenga E, Ntirenganya F Integr Pharm Res Pract. 2024; 13:243-257.

PMID: 39720016 PMC: 11668063. DOI: 10.2147/IPRP.S489143.

Role of the pharmacist caring for people at risk of or living with HIV in Canada.

Tkachuk S, Ready E, Chan S, Hawkes J, Janzen Cheney T, Kapler J Can Pharm J (Ott). 2024; 157(5):218-239.

PMID: 39310805 PMC: 11412478. DOI: 10.1177/17151635241267350.

Using the andersen healthcare utilization model to assess willingness to screen for prep in pharmacy-based settings among cisgender sexually minoritized men: results from the 2020 american men's internet survey.

Alohan D, Evans G, Sanchez T, Harrington K, Quamina A, Young H BMC Public Health. 2024; 24(1):2349.

PMID: 39210291 PMC: 11360873. DOI: 10.1186/s12889-024-19836-5.

Exploring the harm reduction paradigm: the role of Board-Certified Psychiatric Pharmacists.

Douglass A, Maister A, Moeller K, Salwan A, Vallabh A, Waters K Ment Health Clin. 2024; 14(4):253-266.

PMID: 39104432 PMC: 11298032. DOI: 10.9740/mhc.2024.08.253.

Women's preferences for HIV prevention service delivery in pharmacies during pregnancy in Western Kenya: a discrete choice experiment.

Mugambi M, Odhiambo B, Dollah A, Marwa M, Nyakina J, Kinuthia J J Int AIDS Soc. 2024; 27 Suppl 1:e26301.

PMID: 38965978 PMC: 11224584. DOI: 10.1002/jia2.26301.

References

Weidle P, Lecher S, Botts L, Jones L, Spach D, Alvarez J . HIV testing in community pharmacies and retail clinics: a model to expand access to screening for HIV infection. J Am Pharm Assoc (2003). 2014; 54(5):486-92. PMC: 4698873. DOI: 10.1331/JAPhA.2014.14045. View

Elopre L, Kudroff K, Westfall A, Overton E, Mugavero M . Brief Report: The Right People, Right Places, and Right Practices: Disparities in PrEP Access Among African American Men, Women, and MSM in the Deep South. J Acquir Immune Defic Syndr. 2016; 74(1):56-59. PMC: 5903558. DOI: 10.1097/QAI.0000000000001165. View

Lewis C, Rivera A, Crawford N, DeCuir J, Amesty S . Pharmacy-randomized intervention delivering HIV prevention services during the syringe sale to people who inject drugs in New York City. Drug Alcohol Depend. 2015; 153:72-7. PMC: 6688752. DOI: 10.1016/j.drugalcdep.2015.06.006. View

ROSENBLUTH S, Madhavan S, Borker R, Maine L . Pharmacy immunization partnerships: a rural model. J Am Pharm Assoc (Wash). 2001; 41(1):100-7. DOI: 10.1016/s1086-5802(16)31210-4. View

Pollini R, Rudolph A, Case P . Nonprescription syringe sales: a missed opportunity for HIV prevention in California. J Am Pharm Assoc (2003). 2015; 55(1):31-40. PMC: 4293079. DOI: 10.1331/JAPhA.2015.14148. View

Cocohoba J, Althoff K, Cohen M, Hu H, Cunningham C, Sharma A . Pharmacist counseling in a cohort of women with HIV and women at risk for HIV. Patient Prefer Adherence. 2012; 6:457-63. PMC: 3393123. DOI: 10.2147/PPA.S30797. View

Collins B, Bronson H, Elamin F, Yerkes L, Martin E . The "No Wrong Door" Approach to HIV Testing: Results From a Statewide Retail Pharmacy-Based HIV Testing Program in Virginia, 2014-2016. Public Health Rep. 2018; 133(2_suppl):34S-42S. PMC: 6262519. DOI: 10.1177/0033354918801026. View

Zaller N, Jeronimo A, Bratberg J, Case P, Rich J . Pharmacist and pharmacy staff experiences with non-prescription (NP) sale of syringes and attitudes toward providing HIV prevention services for injection drug users (IDUs) in Providence, RI. J Urban Health. 2010; 87(6):942-53. PMC: 3005095. DOI: 10.1007/s11524-010-9503-z. View

Fuller C, Galea S, Caceres W, Blaney S, Sisco S, Vlahov D . Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. Am J Public Health. 2006; 97(1):117-24. PMC: 1716247. DOI: 10.2105/AJPH.2005.069591. View

10.

Meyerson B, Davis A, Agley J, Shannon D, Lawrence C, Ryder P . Predicting pharmacy syringe sales to people who inject drugs: Policy, practice and perceptions. Int J Drug Policy. 2018; 56:46-53. PMC: 6375077. DOI: 10.1016/j.drugpo.2018.02.024. View

11.

Buchbinder S, Liu A . CROI 2019: advances in HIV prevention and plans to end the epidemic. Top Antivir Med. 2019; 27(1):8-25. PMC: 6550360. View

12.

Kibicho J, Owczarzak J . Pharmacists' strategies for promoting medication adherence among patients with HIV. J Am Pharm Assoc (2003). 2011; 51(6):746-55. PMC: 4371784. DOI: 10.1331/JAPhA.2011.10190. View

13.

Hoth A, Shafer C, Dillon D, Mayer R, Walton G, Ohl M . Iowa TelePrEP: A Public-Health-Partnered Telehealth Model for Human Immunodeficiency Virus Preexposure Prophylaxis Delivery in a Rural State. Sex Transm Dis. 2019; 46(8):507-512. DOI: 10.1097/OLQ.0000000000001017. View

14.

Cocohoba J, Murphy P, Pietrandoni G, Guglielmo B . Improved antiretroviral refill adherence in HIV-focused community pharmacies. J Am Pharm Assoc (2003). 2012; 52(5):e67-73. PMC: 4607273. DOI: 10.1331/JAPhA.2012.11112. View

15.

Murphy P, Cocohoba J, Tang A, Pietrandoni G, Hou J, Guglielmo B . Impact of HIV-specialized pharmacies on adherence and persistence with antiretroviral therapy. AIDS Patient Care STDS. 2012; 26(9):526-31. PMC: 4088351. DOI: 10.1089/apc.2012.0189. View

16.

Darin K, Scarsi K, Klepser D, Klepser S, Reeves A, Young M . Consumer interest in community pharmacy HIV screening services. J Am Pharm Assoc (2003). 2014; 55(1):67-72. DOI: 10.1331/JAPhA.2015.14069. View

17.

Rudolph A, Standish K, Amesty S, Crawford N, Stern R, Badillo W . A community-based approach to linking injection drug users with needed services through pharmacies: an evaluation of a pilot intervention in New York City. AIDS Educ Prev. 2010; 22(3):238-51. PMC: 2883795. DOI: 10.1521/aeap.2010.22.3.238. View

18.

Shaeer K, Sherman E, Shafiq S, Hardigan P . Exploratory survey of Florida pharmacists' experience, knowledge, and perception of HIV pre-exposure prophylaxis. J Am Pharm Assoc (2003). 2014; 54(6):610-7. DOI: 10.1331/JAPhA.2014.14014. View

19.

Crawford N, Blaney S, Amesty S, Rivera A, Turner A, Ompad D . Individual- and neighborhood-level characteristics associated with support of in-pharmacy vaccination among ESAP-registered pharmacies: pharmacists' role in reducing racial/ethnic disparities in influenza vaccinations in New York City. J Urban Health. 2011; 88(1):176-85. PMC: 3042083. DOI: 10.1007/s11524-010-9541-6. View

20.

Lutnick A, Case P, Kral A . Injection drug users' perspectives on placing HIV prevention and other clinical services in pharmacy settings. J Urban Health. 2012; 89(2):354-64. PMC: 3324615. DOI: 10.1007/s11524-011-9651-9. View